Lv12
50 积分 2024-09-15 加入
Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials
1天前
已完结
Pharmacokinetics, Safety, and Tolerability of Vonoprazan‐ or Esomeprazole‐Based Bismuth‐Containing Quadruple Therapy: A Phase 1, Double‐Blind, Parallel‐Group Study in Adults with Helicobacter pylori Infection in China
6天前
已完结
Proton pump inhibitor use: systematic review of global trends and practices
6天前
已完结
Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
7天前
已关闭
Revolution of Helicobacter pylori treatment
17天前
已完结
Eradication rate and adherence with high‐dose amoxicillin and proton pump inhibitor as first‐line treatment for Helicobacter pylori infection: Experience from University Hospital in Chile
18天前
已完结
Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis
19天前
已完结
A deep learning-driven discovery of berberine derivatives as novel antibacterial against multidrug-resistant Helicobacter pylori
19天前
已完结
皖公网安备34019202002308
